Skip to main content

Advertisement

Log in

Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal–induced seizures and delirium tremens

  • ORIGINAL PAPER
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Objective

Ethanol–inhibited glutamatergic neurotransmission has been shown to mediate pathophysiological mechanisms in the development of alcoholism, including withdrawal symptoms. NMDA–receptor 2B (NR2B) is a subunit that confers a high sensitivity to ethanol–induced inhibition. Previously we had reported a lack of association between the single nucleotide polymorphism (SNP) rs1806201 in the NR2B gene (GRIN2B) and alcoholism. Shortly thereafter, an association between the polymorphism and early–onset alcoholism has been reported. One aim of the present study was to test whether the association between the GRIN2B polymorphism rs1806201 and early–onset alcoholism can be replicated in a larger sample. Moreover, we hypothesized that another genetic variation within GRIN2B (rs1806191) may have an effect in the etiology of alcoholism or withdrawal–related traits.

Methods

We extended our original study sample to a size of 377 patients and 464 healthy volunteers and performed a replication study, including the second GRIN2B SNP. Associations between allele, genotype and haplotype frequencies of the two polymorphisms and alcoholism as well as with patients’ phenotypes were investigated.

Results

No associations were found between any of the two polymorphisms, tested individually or as haplotypes, and alcoholism, respectively withdrawal–related traits.

Conclusion

Neither the analyzed SNPs nor any of their haplotypes likely modify susceptibility to alcohol dependence or withdrawal–related phenotypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alderborn A, Kristofferson A, Hammerling U (2000) Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 10:1249–1258

    Article  CAS  PubMed  Google Scholar 

  2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed.Washington, DC, American Psychiatric Press

  3. Allgaier C, Scheibler P, Muller D, Feuerstein TJ, Illes P (1999) NMDA receptor characterization and subunit expression in rat cultured mesencephalic neurones. Br J Pharmacol 126:121–130

    CAS  PubMed  Google Scholar 

  4. Buchholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr, Reich T, Schmidt I, Schuckit MA (1994) A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 55:149–158

    PubMed  Google Scholar 

  5. Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–121

    Article  PubMed  Google Scholar 

  6. Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 56:385–431

    Google Scholar 

  7. Fink K, Gothert M (1996) Both ethanol and ifenprodil inhibit NMDA-evoked release of various neurotransmitters at different, yet proportional potency: potential relation to NMDA receptor subunit composition. Naunyn Schmiedebergs Arch Pharmacol 354:312–319

    Article  CAS  PubMed  Google Scholar 

  8. Gulya K, Grant KA, Valverius P, Hoffman PL, Tabakoff B (1991) Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res 547:129–134

    Article  CAS  PubMed  Google Scholar 

  9. Hesselbrock MN, Easton C, Buchholz KK, Schuckit M, Hesselbrock V (1999) A validity study of the SSAGA – a comparison with the SCAN. Addiction 94:1361–1370

    Article  CAS  PubMed  Google Scholar 

  10. Iorio KR, Reinlib L, Tabakoff B, Hoffman PL (1992) Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. Mol Pharmacol 41:1142–1148

    Google Scholar 

  11. Johnson BA, Ait-Daoud N (2000) Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology (Berl) 149:327–344

    Article  CAS  PubMed  Google Scholar 

  12. Kendler KS, Neale MC, Heath AC, Kessler RC, Eaves LJ (1994) A twin-family study of alcoholism in women. Am J Psychiatry 151:707–715

    CAS  PubMed  Google Scholar 

  13. Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S, Stetson P, Trevisan LA, Charney DS (1998) Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch Gen Psychiatry 55:354–360

    Article  CAS  PubMed  Google Scholar 

  14. Krystal JH, Petrakis IL, Limoncelli D, Webb E, Gueorgueva R, D’Souza DC, Boutros NN, Trevisan L, Charney DS (2003) Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients. Neuropsychopharmacology 28:2020–2028

    Google Scholar 

  15. Masood K, Wu C, Brauneis U, Weight FF (1994) Differential ethanol sensitivity of recombinant N-methyl-D-aspartate receptor subunits. Mol Pharmacol 45:324–329

    Google Scholar 

  16. Preuss UW, Soyka M, Bahlmann M, Wenzel K, Behrens S, de Jonge S, Kruger M, Bondy B (2000) Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), 3H-paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationship to impulsivity. Psychiatry Res 96:51–61

    Article  CAS  PubMed  Google Scholar 

  17. Preuss UW, Koller G, Soyka M, Bondy B (2001) Association between suicide attempts and 5-HTTLPR-S-Allele in alcohol dependent and controls: Further evidence from a German alcoholdependent inpatient sample. Biol Psychiatry 50:636–639

    Article  CAS  PubMed  Google Scholar 

  18. Nishiguchi N, Shirakawa O, Ono H, Hashimoto T, Maeda K (2000) Novel polymorphism in the gene region encoding the carboxylterminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. Am J Psychiatry 157:1329–1331

    Article  CAS  PubMed  Google Scholar 

  19. Peoples RW, Stewart RR (2000) Alcohols inhibit N-methyl-D-aspartate receptors via a site exposed to the extracellular environment. Neuropharmacology 39:1681–1691

    Google Scholar 

  20. Prescott CA,Kendler KS (1999) Genetic and environmental contributions to alcohol abuse and dependence in a populationbased sample of male twins. Am J Psychiatry 156:34–40

    CAS  PubMed  Google Scholar 

  21. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgansberger W, Schadrack J (2001) The anticraving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40:749–760

    Google Scholar 

  22. Rice JP, Reich T, Bucholz KK, Neuman RJ, Fishman R, Rochberg N, Hesselbrock VM, Nurnberger JI Jr, Schuckit MA, Begleiter H (1995) Comparison of direct interview and family history diagnoses of alcohol dependence. Alcohol Clin Exp Res 19:1018–1023

    CAS  PubMed  Google Scholar 

  23. Sass H, Soyka M, Mann K, Zieglgaensberger W (1996) Relapse prevention by acamprosate: results from a placebo controlled study on alcohol dependence. Arch Gen Psychiatry 53:673–680

    CAS  PubMed  Google Scholar 

  24. Schuetz CG, Soyka M (2000) Dextrometorphan challenge in alcohol- dependent patients and controls. Arch Gen Psychiatry 57:291–292

    Google Scholar 

  25. Schumann G, Rujescu D, Szegedi A, Singer P,Wiemann S, Wellek S, Giegling I, Klawe C, Anghelescu I, Heinz A, Spanagel R, Mann K, Henn FA, Dahmen N (2003) No association of alcohol dependence with a NMDA-receptor 2B gene variant. Mol Psychiatry 8:11–12

    Article  CAS  PubMed  Google Scholar 

  26. Selzer M (1971) Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. Am J Psychiatry 127:1653–1658

    CAS  PubMed  Google Scholar 

  27. Sillaber I, Rammes G, Zimmermann S, Mahal B, Zieglgansberger W, Wurst W, Holsboer F, Spanagel R (2002) Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 296:931–933

    Article  CAS  PubMed  Google Scholar 

  28. Sham PC, Curtis D (1995) Monte-Carlo tests for association between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97–105

    PubMed  Google Scholar 

  29. Soyka M, Bondy B, Eisenburg B, Schuetz CG (2000) NMDA receptor challenge with dextrometorphan – subjective response, neuroendocrinological findings and possible clinical implications. J Neural Transm 107:710–714

    Google Scholar 

  30. Soyka M, Preuss UW, Koller G, Zill P, Bondy B (2002) Dopamine D4 receptor polymorphism in extraversion revisited: Results from the Munich Gene Bank Project for Alcoholism. J Psychiatry Res 36:429–435

    CAS  Google Scholar 

  31. Spanagel R, Holter SM, Allingham K, Landgraf R, Zieglgansberger W (1996) Acamprosate and alcohol: I Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:39–44

    Article  CAS  PubMed  Google Scholar 

  32. Spanagel R, Zieglg.nsberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54–59

    Article  CAS  PubMed  Google Scholar 

  33. Spanagel R,Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521–527

    Article  CAS  PubMed  Google Scholar 

  34. Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psychiatry 152:332–340

    CAS  PubMed  Google Scholar 

  35. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173–184

    Article  CAS  PubMed  Google Scholar 

  36. Tyndale RF (2003) Genetics of alcohol and tobacco use in humans. Ann Med 35:94–121

    Article  CAS  PubMed  Google Scholar 

  37. Wernicke C,Samochowiec J, Schmidt LG, Winterer G, Smolka M, Kucharska-Mazur J, Horodnicki J, Gallinat J, Rommelspacher H (2003) Polymorphisms in the N-Methyl-D-Aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Biol Psychiatry 54:922–928

    Article  CAS  PubMed  Google Scholar 

  38. Wittchen H, Zaudig M, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV, Achse I und II. Hogrefe, Goettingen

  39. Wittchen H, Lachner G, Wunderlich U, Pfister H (1998) Testretest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568–578

    Article  CAS  PubMed  Google Scholar 

  40. World Health Organization (1992) International Classification of Diseases. In: Clinical Descriptions Diagnostic Guidelines, 10th rev. (ed) Geneva: World Health Organization

  41. Wright JM, Peoples RW, Weight FF (1996) Single-channel and whole-cell analysis of ethanol inhibition of NMDA-activated currents in cultured mouse cortical and hippocampal neurons. Brain Res 738:249–256

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Tadic MD.

Additional information

The study was supported by a MAIFOR grant of the University of Mainz (AT, ND, AS) and by the Bundesministerium für Bildung und Forschung, BMBF, Grant No. 01EB0140–42 (MS)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tadic, A., Dahmen, N., Szegedi, A. et al. Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal–induced seizures and delirium tremens. Eur Arch Psychiatry Clin Neurosci 255, 129–135 (2005). https://doi.org/10.1007/s00406-004-0545-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-004-0545-7

Key words

Navigation